혈관 접근 기기 시장

The vascular access devices market was valued at US$ 6.51 billion in 2024 and is anticipated to reach US$ 11.10 billion by 2031, with a projected CAGR of 7.9% from 2025 to 2031.

Market Insights and Analyst Perspective:Vascular access devices are utilized through various anatomical sites to access the superior or inferior vena cava, including the internal jugular vein, subclavian vein, external jugular vein, and femoral vein. The expansion of the vascular access devices market is primarily driven by the increasing incidence of chronic diseases and the growing demand for chemotherapy treatments. Furthermore, strategic actions by companies to maintain competitiveness in the market contribute to this growth. A notable rise in the adoption of AI-enabled robotic venous access devices is expected to introduce new trends in the vascular access device market throughout the forecast period.

Growth Factors and Challenges:Chemotherapy serves as a primary or adjunctive treatment aimed at reducing or eradicating tumors through potent drug administration. Consequently, the rising number of cancer cases boosts the demand for chemotherapy procedures. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases reported worldwide in 2020, resulting in approximately 10 million deaths. The National Cancer Registry (NCR) in South Africa reported around 110,000 new cancer diagnoses and over 56,000 cancer-related fatalities in 2020. Additionally, the disease burden is expected to escalate in the coming decades, with projections of new cancer cases reaching 138,000 and 175,000 by 2030 and 2040, respectively, while cancer-related deaths are anticipated to rise to 73,000 and 94,000 in those years. Thus, the increasing prevalence of cancer propels the growth of the vascular access devices market.

Strategic Insights

Report Segmentation and Scope:The analysis of the vascular access devices market has been conducted by examining the following segments: product type, application, route of insertion, end user, and geography. The market is categorized by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In terms of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood product transfusion, and others. The route of insertion divides the market into subcutaneous and intravenous. By end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The geographical scope of the vascular access devices market report includes North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:The vascular access devices market is segmented by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In 2022, the short peripheral intravenous catheter segment held the largest share of the vascular access devices market and is projected to exhibit the highest CAGR from 2022 to 2030.

In terms of application, the vascular access devices market is divided into drug administration, fluid and nutrition administration, blood product transfusion, and others. The drug administration segment accounted for the largest share in 2022 and is expected to show the highest CAGR during the period from 2022 to 2030.

Regarding the route of insertion, the vascular access devices market is split into subcutaneous and intravenous. The intravenous segment captured a larger market share in 2022 and is predicted to achieve a higher CAGR from 2022 to 2030.

By end user, the market is categorized into hospitals and clinics, ambulatory surgical centers, and others. The vascular access devices market for hospitals and clinics is anticipated to grow during the period from 2022 to 2030.

Regional Analysis:North America is the leading contributor to the global growth of the vascular access devices market. The Asia Pacific region is expected to experience the highest CAGR in the market from 2022 to 2030. North America held the largest share of the global market in 2022, driven by the increasing prevalence of chronic conditions, a growing elderly population, the presence of key market players engaged in product development, and advancements in technology. In North America, the US accounted for the largest market share in 2022.

Vascular Access Devices Market Report Scope

Industry Developments and Future Opportunities:The forecast for the vascular access devices market is based on various secondary and primary research findings, including key company publications, association data, and databases. According to press releases from major market players, several strategies are outlined below:

In November 2023, BD (Becton, Dickinson, and Company) introduced new needle-free blood draw technology compatible with integrated catheters, supporting the company's vision of a "One-Stick Hospital Stay." The PIVO Pro Needle-free Blood Collection Device features design enhancements for compatibility with integrated and long peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.In May 2023, Teleflex Inc. launched two new devices-Arrow VPS Rhythm DLX Device and NaviCurve Stylet-aimed at improving PICC insertion procedures and minimizing complications. The VPS Rhythm DLX Device offers real-time catheter tip location information by utilizing the patient's cardiac electrical activity. The NaviCurve Stylet is designed with an anatomical curve and flexible tip to self-orient to patient anatomy for better PICC advancement into the superior vena cava (SVC) for successful insertion.

Competitive Landscape and Key Companies:Teleflex Inc, BD, B. Braun SE, Terumo Medical Corporation, Medtronic, Fresenius Kabi, Baxter, Vygon SAS, Kimal, and Access Vascular Inc are among the key players highlighted in the vascular access devices market report. Additionally, several other companies have been examined and analyzed to provide a comprehensive view of the market and its ecosystem. These companies are focused on geographic expansion and new product launches to meet the increasing demand from consumers globally and to enhance their product offerings in specialty portfolios. Their global presence enables them to cater to a vast customer base, thereby facilitating market growth.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 Market Definition, Assumptions and Limitations
• 1.3 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Vascular Access Devices Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
• 4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Vascular Access Devices Market - Key Market Dynamics

• 5.1 Key Market Drivers
• 5.2 Key Market Restraints
• 5.3 Key Market Opportunities
• 5.4 Future Trends
• 5.5 Impact Analysis of Drivers and Restraints

6. Vascular Access Devices Market - Global Market Analysis

• 6.1 Vascular Access Devices - Global Market Overview
• 6.2 Vascular Access Devices - Global Market and Forecast to 2030

7. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

• 7.1 Overview
• 7.2 Short Peripheral Intravenous Catheters
• 7.3 Midline Catheters
• 7.4 PICC
• 7.5 Central Catheters
  • 7.5.1 Centrally Inserted central Catheters
  • 7.5.2 Femoral Inserted Central Catheters
• 7.6 Implantable Ports
• 7.7 Accessories

8. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Application, 2020-2030

• 8.1 Overview
• 8.2 Drug Administration
• 8.3 Blood Transfusion
• 8.4 Fluid and Nutrition Administration
• 8.5 Others

9. Vascular Access Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

• 9.1 Overview
• 9.2 Hospitals and Clinics
• 9.3 Ambulatory Surgical Centers
• 9.4 Others

10. Vascular Access Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

• 10.1 North America
  • 10.1.1 North America Vascular Access Devices Market Overview
  • 10.1.2 North America Vascular Access Devices Market Revenue and Forecasts to 2030
  • 10.1.3 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Type
  • 10.1.4 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Application
  • 10.1.5 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By End User
  • 10.1.6 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Countries
    • 10.1.6.1 United States Vascular Access Devices Market
      • 10.1.6.1.1 United States Vascular Access Devices Market, by Type
      • 10.1.6.1.2 United States Vascular Access Devices Market, by Application
      • 10.1.6.1.3 United States Vascular Access Devices Market, by End User
    • 10.1.6.2 Canada Vascular Access Devices Market
      • 10.1.6.2.1 Canada Vascular Access Devices Market, by Type
      • 10.1.6.2.2 Canada Vascular Access Devices Market, by Application
      • 10.1.6.2.3 Canada Vascular Access Devices Market, by End User
    • 10.1.6.3 Mexico Vascular Access Devices Market
      • 10.1.6.3.1 Mexico Vascular Access Devices Market, by Type
      • 10.1.6.3.2 Mexico Vascular Access Devices Market, by Application
      • 10.1.6.3.3 Mexico Vascular Access Devices Market, by End User
• 10.2 Europe
  • 10.2.1 Germany
  • 10.2.2 France
  • 10.2.3 Italy
  • 10.2.4 Spain
  • 10.2.5 United Kingdom
  • 10.2.6 Rest of Europe
• 10.3 Asia-Pacific
  • 10.3.1 Australia
  • 10.3.2 China
  • 10.3.3 India
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 Rest of Asia-Pacific
• 10.4 Middle East and Africa
  • 10.4.1 South Africa
  • 10.4.2 Saudi Arabia
  • 10.4.3 U.A.E
  • 10.4.4 Rest of Middle East and Africa
• 10.5 South and Central America
  • 10.5.1 Brazil
  • 10.5.2 Argentina
  • 10.5.3 Rest of South and Central America

11. Industry Landscape

• 11.1 Mergers and Acquisitions
• 11.2 Agreements, Collaborations, Joint Ventures
• 11.3 New Product Launches
• 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

• 12.1 Heat Map Analysis by Key Players
• 12.2 Company Positioning and Concentration

13. Vascular Access Devices Market - Key Company Profiles

• 13.1 B Braun Melsungen AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 NIPRO Medical Corporation
• 13.3 Smiths Medical
• 13.4 Becton, Dickinson, and Company
• 13.5 Terumo Corporation
• 13.6 Teleflex Incorporated
• 13.7 Edwards Lifesciences Corporation
• 13.8 AngioDynamics
• 13.9 Ameco Medical
• 13.10 Vygon Ltd

14. Appendix

• 14.1 Glossary
• 14.2 About The Insight Partners
• 14.3 Market Intelligence Cloud